The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
decitabine · Kit
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 50 mg/20mL · Injection, Powder, Lyophilized, For Solution · #1 vial/carton / 20 ml in 1 vial · 50 mg/10mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 10 ml in 1 vial, single-dose
What changed in the last 90 days
Every detected change for decitabine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- DecitabineSep 3, 2026New productBluePoint Laboratories
- DecitabineJul 18, 2026New productJiangsu Hansoh Pharmaceutical Group Co., Ltd.
Same drug class
Other molecules FDA puts in Nucleoside Metabolic Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- pentostatin· in shortage
- azacitidine· in shortage
- (daunorubicin and cytarabine) liposome· 1 maker
- azacitidine for· 1 maker
- fluorouracil cream, 0.5%· 1 maker
- gemcitabine intravesical· 1 maker
- purixan· 1 maker
- trifluridine and tipiracil· 1 maker
- cedazuridine and decitabine· 3 makers
- trifluridine· 6 makers
- mercaptopurine· 7 makers
- cytarabine· 9 makers
Common questions
- Is Decitabine in shortage right now?
- No. FDA does not currently list Decitabine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Decitabine?
- 31 companies have marketed Decitabine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.